(Q36953143)

17 August 2017

1 reference

title

Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody (English)

1 reference

17 August 2017

1 reference

1 reference

11

1 reference

17 August 2017

Lepelletier Y

3

0 references

Ivan C Moura

object named as

Moura IC

2

0 references

author name string

Callens C

1

1 reference

17 August 2017

Coulon S

4

1 reference

17 August 2017

Renand A

5

1 reference

17 August 2017

Dussiot M

6

1 reference

17 August 2017

Ghez D

7

1 reference

17 August 2017

Benhamou M

8

1 reference

17 August 2017

Monteiro RC

9

1 reference

17 August 2017

Bazarbachi A

10

1 reference

17 August 2017

27 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

22

1 reference

17 August 2017

1

1 reference

17 August 2017

42-48

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404958

17 August 2017

0 references

cites work

The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Global epidemiology of HTLV-I infection and associated diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Long-term serological outcome of infants who received frozen-thawed milk from human T-lymphotropic virus type-I positive mothers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

New therapeutic approaches for adult T-cell leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

The transferrin receptor: role in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Transferrin receptor expression and the control of cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Binding of apotransferrin to K562 cells: explanation of the transferrin cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Iron metabolism and the IRE/IRP regulatory system: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Transferrin receptors in human tissues: their distribution and possible clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Transferrin and transferrin receptors in carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Transferrin Binding by Peripheral Blood Mononuclear Cells in Human Lymphomas, Myelomas and Leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Transferrin receptor 2: a new molecule in iron metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Regulation of transferrin receptor 2 protein levels by transferrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Transferrin receptor 2 protein is not expressed in normal erythroid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Transferrin receptor 2 is frequently expressed in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Murine cell surface transferrin receptor: Studies with an anti-receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Monoclonal antibody successes in the clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404958

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404958

1 reference

17 August 2017

1 reference